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Abstract
Since its discovery 75 years ago, a wealth of knowledge has accumulated on the role of 
cardiolipin, the hallmark phospholipid of mitochondria, in bioenergetics and particularly on the 
structural organization of the inner mitochondrial membrane. A surge of interest in this anionic 
doubly-charged tetra-acylated lipid found in both prokaryotes and mitochondria has emerged 
based on its newly discovered signaling functions. Cardiolipin displays organ, tissue, cellular and 
transmembrane distribution asymmetries. A collapse of the membrane asymmetry represents a 
pro-mitophageal mechanism whereby externalized cardiolipin acts as an “eat-me” signal. 
Oxidation of cardiolipin's polyunsaturated acyl chains - catalyzed by cardiolipin complexes with 
cytochrome c. - is a pro-apoptotic signal. The messaging functions of myriads of cardiolipin 
species and their oxidation products are now being recognized as important intracellular and 
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extracellular signals for innate and adaptive immune systems. This newly developing field of 
research exploring cardiolipin signaling is the main subject of this review.
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If you are out to describe truth, leave elegance to the tailor
– Albert Einstein
Introduction
Eukaryotic cells are believed to have evolved from a chimeric combination of an archaeon 
and bacterium [1-3]. Their subsequent evolution to multicellular organisms changed the 
biosphere and geology of our planet [4, 5]. This review will focus on the ancient, conserved 
and intriguing lipid, cardiolipin (CL) and its signaling functions. Understanding the context 
of how eukaryotic cells and subsequently multicellular organisms became so systemically 
prominent provides clues to eukaryotic cellular diversity, adaptation and survival. Evidence 
based on genomic studies suggests that a bacterial ancestor of the eukaryotic cell evolved 
into mitochondria (and chloroplasts) [3, 6]. Mitochondria allow aerobic eukaryotes to 
generate vastly more ATP per cell than their prokaryotic ancestors. Eukaryotes have up to 
4-5 orders of magnitude more energy per gene than do bacteria and thus have a huge 
evolutionary edge over prokaryotes in adapting to changing environments [3]. This energetic 
and metabolic complexity, however, requires immensely more sophisticated communications 
between the cellular and mitochondrial components, thus demanding and stimulating new 
signaling and control mechanisms and pathways.
In both mitochondria and bacteria, in addition to ionic gradients, substrate oxidation-linked 
electron transport through the proton-extruding respiratory complexes I, III and IV forms a 
trans-membrane proton gradient [7]. Transduction of this proton gradient energy to ATP 
synthesis via complex V is a core function of mitochondria in aerobic eukaryotic cells. 
Respiratory complexes I, II and III also reduce O2 to O2•−. Disproportionation of O2•− 
catalyzed by superoxide dismutase forms H2O2, a potent source of oxidizing equivalents [8], 
is utilized in many signaling reactions [9-12]. The importance of H2O2 dependent reactions 
catalyzed by many metalloproteins, particularly heme-peroxidases, is so high that the 
functional significance of superoxide dismutase enzymatic activity may be attributed not to 
the elimination of O2•− but to the synthesis of H2O2 [13]. Notably, not only electron 
transport complexes but also several mitochondrial dehydrogenase complexes, such as 
pyruvate and 2-oxoglutarate dehydrogenases, are major potential sources of O2•−. The 
formation of O2•− is dependent in part on the electrochemical gradient and the redox state of 
electron transport components which is also dependent on oxygen and the redox balance of 
the cell[14]. Collectively mitochondrial and cellular oxidants are often referred to as reactive 
oxygen species (ROS) [15, 16].
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Eukaryotic cells capable of replication have mitochondria (with one known exception, [17]) 
and this includes anaerobic eukaryotes that do not generate ATP using a “bioenergetic” 
membrane. The functions of the mitochondria clearly extend beyond ATP production. 
Mitochondria have a bacterial type circular genome in multiple copies that is separate from 
but is coordinated with the nuclear genome [18, 19] but the number of mitochondrial genes 
is less than 1% of their proteome. Significant gene loss also occurs in obligate intracellular 
pathogens and symbionts and even descriptions of the minimum gene size needed by 
engineered bacteria are now being defined[20, 21]. Why the mitochondrial genome is even 
preserved at all is not clear, but the mitochondrial genome codes for 13 mRNA's that 
translate to membrane protein constituents of the respiratory chain as well as for the tRNA 
for a 12 S and 16S ribozyme and for 22 tRNAs [18]. As mitochondria are present in most 
anaerobic eukaryotes, non-ATP generating functions of mitochondria, notably signaling and 
control mechanisms, may have dictated the evolutionary preservation of the mitochondrial 
genome. In spite of the likely relevance of the mitochondrial genome to non-bioenergetic 
functions of the organelle, all the 13 mitochondrial genes encode subunits of electron 
transport complexes. The enigma of the essentiality of mitochondria and mtDNA remains 
unresolved.
While maintaining their ATP generating functions mitochondria must undergo biogenesis, 
mitophagy and turnover of their complex membrane systems to optimize their many 
functions. The proteins comprising the respiratory chain, mitochondrial transport systems 
and protein synthesis along with a cohort of mitochondrial specific lipids are ancient and 
highly conserved mitochondrial constituents. A hallmark mitochondrial lipid present in all 
“bioenergetic” prokaryotic and mitochondrial membranes is CL. Cardiolipin is a unique 
double-charged tetra-acyl chained phospholipid that is conserved in bacteria and 
mitochondria. Functions ascribed to CL include maintaining a non-spheroidal membrane 
structure, binding specifically to membrane proteins, respiratory and super-complex 
stabilization and signaling [22-31]. The signaling features of CL are the focus of this review. 
The mitochondrial CL differs from its prokaryotic precursor by having diverse 
polyunsaturated acyl side chains. In addition to structurally altering the membrane bilayer, 
polyunsaturated acyls are also oxidation targets giving rise to myriads of signaling lipid 
mediators [32] The initially synthesized nascent mitochondrial CLs may include a variety of 
acyls (32 fatty acid residues in Lipid Maps (www.lipidmaps.org) generating a highly 
diversified molecular speciation of CLs. In several tissues, however, the nascent CLs with 
different acyls (hetero-acylated CLs) undergo subsequent synthetic transformations - a 
process also called remodeling - to form CLs with identical acyls, homo-acylated CLs 
[33-36]. This stage of the biosynthesis requires remarkable specificity of the engaged 
enzymatic catalysts as it has to overcome the entropy-driven diversification of randomly 
integrated acyls in favor of stochastically almost impossible selection of only few homo-
acylated CL species. The predominant presence of tetra-linoleoyl CLs in the heart, skeletal 
muscles and liver of mammals [35, 37, 38] illustrates the extraordinary transacylase 
selectivity of the process. While it is evident that high levels of selectivity is presumably 
associated with some function of homo-acylated polyunsaturated fatty acid (PUFA) CLs, 
their actual unique role remains unidentified. It is noteworthy, however, that this exceptional 
and “energetically expensive” selectivity may be a mammalian evolutionary achievement as 
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phylogenetically more ancient eukaryotic organisms, like cold blooded fish, do not display 
the selective accumulation of homo-acylated CLs in heart and liver. In Fig. 1A-B the hetero-
acylation of CLs detected in the brain, heart and skeletal muscle of Northern Red Snapper 
(Lutjanus campechanus) is contrasted with bovine heart which is mostly homo-acylated. 
Figure 1 compares the diversification and the preponderance of different molecular species 
of CL in the fish and bovine heart. The fish has a CL hetero-acylation that more closely 
resembles the diverse range of CL seen in the mammalian brain – which has the highest 
tissue diversification in mammalian tissues [39-41]. The enormous diversity of Cls in the 
heart of a fish (Northern Red Snapper) contrasts with extremely high dominance of homo-
acylated tetralinoleoyl-CL in the bovine heart.
While CLs and oxidized products derived from them are now recognized as a rich and 
diverse source of cell signals, the significance of the diversification vs uniformity of CL is 
still enigmatic and represents an exciting field of future research [35, 42-44]. In this context, 
CLs and their oxidation products should be recognized as a novel cellular signaling language 
that is part of and integral to, many cellular functions [22, 24, 26, 45]. The complexity 
required for a harmonized spatiotemporal organization of the myriads of reactions in a 
multi-cellular organism as well as interactions with extra- and intracellular bacterial 
pathogens, involving CL, is apparent. This includes signaling during cell death, mitophagy, 
innate immunity and potentially many hereto unknown signaling functions. With increasing 
signaling complexity, the potential for defects derived from CL biosynthesis resulting in 
pathology is already apparent in Barth Syndrome [33, 35, 46-48] and it is likely other 
diseases linked to CL structure, location and stability may subsequently be defined.
This review is not at all intended to restate or rework the many fine reviews about CL, which 
nicely summarize and review the explosion of new literature and knowledge about CLs [26, 
35, 42-44, 49-51]. Instead, our focus will be on issues of CL as a signal that are not well 
understood and require wisdom and experimental precision to unravel. We will provide a 
brief overview of CL structure and synthesis pertaining to its role in cellular signaling. A 
more detailed discussion of CL binding to proteins, especially cytochrome c (cyt c), its 
asymmetric distribution in the mitochondria, the scope of CL diversity and the role of CL in 
mitophagy, apoptosis and innate and adaptive immunity will provide opportunities for the 
reader to understand that CLs function as sophisticated cell signals. While our understanding 
of the complex differential tissue distribution of unsaturated and oxidized CL and its role in 
cell signaling is just now becoming apparent, we trust that the readers of this review will 
grasp the depth and complexity that CLs play in biology.
Cardiolipin, Its Molecular Structure, Homo- and Hetero-acylated Species, 
Asymmetry – Links with the Biosynthesis
Structure and ionization state
Cardiolipin, (1,3-bis(sn-3’-phosphatidyl)-sn-glycerol) demonstrates a molecular asymmetry, 
an acyl chain asymmetry and a membrane distribution asymmetry which are integral 
features of its functions in mitochondria. Cardiolipin is a dimeric phosphatidic acid with a 
“backbone” glycerol containing a prochiral central carbon, two phosphates and 4 acyl chains 
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(Fig. 1C) [52]. The two phosphates are ionized at physiological pH resulting in CL being a 
doubly-negatively charged amphiphilic lipid. While the pKa of the phosphates of CL had 
originally been described as strong acids and were doubly negatively charged [53], a pH 
titration study comparing a native and 2'-deoxy-glycerol backbone suggested that there was 
both a low and high pKa[54]. Subsequently membrane measurements of CL using external 
proton adsorption, electrophoretic mobility of membranes and magic angle spinning P31 
NMR have clearly shown that the pKa of CL as well as lyso-CL is ~2-3 indicating that both 
phosphates are ionized at physiological pH in lipid bilayers [55-57]. Thus it seems logical or 
almost certain that at physiological pH, CLs in lipid bilayers adopt the states with two fully 
ionized phosphate groups. It remains to be determined whether CL molecules interacting 
with a wide variety of proteins may encounter microenvironments leading to incomplete 
ionization of one or both phosphate groups? It is likely that binding initiated by 
predominantly electrostatic interactions - as happens during CL-induced peroxidase 
activation of cytochrome c with its positive surface charge of ~8+ [58] - is realized with fully 
ionized CLs, as evidenced by the iso-electric behavior of the complexes at a ratio of 1:4 
during electrophoresis [59]. Similarly, 1H-NMR titrations of cyt c/CL complexes (at a 1:4 
ratio) in bilayer membranes display saturable broadening of the characteristic resolved 
signals (Yanamala, et al, personal communications). Whether this arrangement of CL is 
universally characteristic of its interactions with numerous other proteins or rather engages 
singly ionized CL molecules, similar to the predominant formation of its singly-charged 
species in gas phase by electro-spray ionization during mass–spectrometric analysis (see 
below), - is an interesting subject for future studies.
Biosynthesis and Remodeling
Of the three known prokaryotic CL synthetic pathways, mitochondria and actinobacteria 
share a CL synthetic schema utilizing two CDP-diacyl glycerol (CDP-DAG) precursors 
while most prokaryotes use phosphatidyl glycerols. Many more details of these differential 
syntheses have been described elegantly including the stepwise synthesis of CL, has been 
the subject of numerous good recent reports and reviews [51, 60-63]. There are some aspects 
of the initial synthesis that have ramifications for the structure and potentially to the function 
of constitutive and remodeled CLs and this we highlight here.
In mitochondria, in order to attach the two phosphatidyl groups to the 1 and 3 positions of 
the “backbone” glycerol, two molecules of CDP-DAG are required and two separate 
enzymes are used in the synthesis, phosphatidyl-glycerol-phosphate synthetase, and CL 
synthetase. We note that the CDP-DAG has a chiral (R) carbon in position 2 of the glycerol 
and it is not altered during CL synthesis [64]. Accordingly the constitutive CL is synthesized 
with an asymmetry such that any binding across one of the two peripheral chiral centers in 
CL (note shading in Fig 1C), we could call it “trans-chiral binding”, confers a distinct 
binding motif that will differ on the “left” versus “right” sides of CL. This asymmetry is 
independent of the composition of the CL acyl chains. Any imputed function for this 
structural determinant of CL has not been addressed experimentally but may play a role in 
subtle tissue specific CL binding and acyl-chain remodeling.
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There is a divergence between prokaryotic and eukaryotic CL synthesis after its initial 
synthesis. The bacterial CLs undergo limited acyl chain modifications, including (limited) 
formation of plasmalogen acyl chains that contain an alk-1'-enyl ether linkage as 
demonstrated in Clostridium difficile [65]. The mitochondrial CL however undergoes 
massive cell and tissue-dependent enzyme linked acyl-chain remodeling. Following its initial 
synthesis, CL is believed to be de-acylated (possibly by a Ca2+ independent phospholipases 
A2) resulting in formation of monolyso-CL (MLCL) [66-68].
Three separate enzymes have been identified in the remodeling of CL, two are acyl-
transferases requiring an acyl-CoA, and the third is a trans-acylase that can rapidly “re-sort” 
the acyl chains by trans-acylation. While one can envision the acyl-specificity of CLs 
remodeled through acyl-CoA-driven pathways, it is more difficult to ascribe the production 
of acyl-specific, rather than random, CL products formed through entirely stochastic trans-
acylation mechanism. These enzymes are i) MLCL acyltransferase-1 (MLCAT1) which is 
located on the matrix side of the inner mitochondrial membrane (IMM) and has also been 
described as a splice variant of trifunctional protein (TFP). Both TFP and its splice variant 
MLCLAT1 have a role in re-acylating lyso-CL using acyl-CoA [69]. ii) Acyl-CoA:lyso-CL-
acyltransferase-1 (ALCAT1) is located on the outer side of the outer mitochondrial 
membrane (OMM) and also requires an acyl-CoA to acylate MLCL (or di-Lyso CL) [70, 
71]. As either CL or MLCL would need to move from the inner side of the IMM to the outer 
side of the OMM for this enzyme to play a substantive role in CL remodeling, its role in 
remodeling may be limited to a small fraction of the CL pool. iii) Taffazin is a trans-acylase 
located in the inter-membrane space (IMS) in yeast and mammals. [72-76]. It is believed to 
be the major enzyme involved in CL remodeling. As has been mentioned above, the enzyme 
lacks acyl chain specificity and it is unclear how tafazzin-linked CL remodeling can result in 
large fractions of homo-acylated CL species such as for example, tetralinoleoyl-CL (TLCL) 
which constitutes up to 80% of mammalian cardiac and skeletal muscle CL. In contrast to 
muscle tissue, mammalian neural tissue is rich in diverse hetero-acylated CLs [77, 78]. 
While the heart's main function is pumping blood, this requires both a variable and 
uninterrupted energy supply, TLCL may be a CL structure that is speculated to have a 
special role in responding to the high energetic demands needed for the cardiac contractile 
function [79]. Acyl chain substrate availability and nutritional pressure, and/or the removal 
of selected CL-acyl products could drive this enzyme linked trans-acylation to concentrate 
some forms of homo-acylated CL, but details of these enzyme-linked synthetic/remodeling 
activities are lacking. In the absence of tafazzin in yeast mitochondria, homo-acyl-CL is lost 
but the mitochondria still function normally but with a far more hetero-acylated CL 
composition [36, 42, 64]. As the role of remodeled CL is not exclusively to maintain the 
integrity of the mitochondrial inner membrane, alternative functions of CL including 
signaling are likely [80].
Cardiolipin is located asymmetrically within the IMM. Structurally, the four acyl chains of 
CL coupled with the double-negatively charged polar end provide CL with a “conical” 
shape, with the polar region being the cone cusp, and the flexible and variable acyl chains 
being the base of the “cone”. The length, saturation and oxidation of these side chains, 
provide differential influences on the shape, binding, function and stability of CL [35, 48, 
81, 82]. This “conical” shaped and double negatively charged CL is asymmetrically 
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distributed in the IMM with a higher concentration of CL on the inner side of the IMM. The 
respiratory complexes and the adenine nucleotide carrier have an absolute requirement for 
CL and these complexes constitute much of the IMM protein [83-86]. With a high protein/
lipid ratio ~3:1 in the IMM [87] and with CL being about ~20% of the (cardiac) 
mitochondrial phospholipids, the weight ratio of protein/CL phospholipids is ~15:1. It is 
likely much of the CL is utilized to facilitate tight membrane folding [27, 30] and as a “lipid 
stabilizer” of the respiratory complexes and supercomplexes [38, 88-91]. A cryo-EM map of 
one super-complex consisting of a dimer of complex III and two monomers of complex IV 
was reported to contain 50 CLs [92]. Clearly a significant portion of the CL in the IMM is 
bound to respiratory-linked proteins. Thus CL has many obligate protein binding sites in the 
IMM as well as opportunities to relay information about the structural integrity of the 
respiratory complexes and supercomplexes as it tethers lipophilic domains of membrane 
proteins.
The process of synthesizing homo-acylated TLCL may seem cumbersome but why the 
mitochondria in select tissues “remake” CL as mostly homo-acylated CL is open to 
speculation and experimentation. In terms of signaling and even more intriguing are the CL 
modifications that occur to “the rest” of the CL. Hetero-acylated CLs are synthesized with 
varying acyl chain lengths, desaturation and tissue specificity [77, 80]. Each CL species (the 
diversity range and synthetic locations are outlined later in this review) will have subtle 
structural differences and the polyunsaturated acyl chains are each candidates for lipid 
peroxidation. Like their unsaturated phospholipid counterparts, many CL oxidation products 
have the potential to convey information to receptors of lipid oxidation products. Oxidized 
CL acyl chain fragments can dissociate from CL to convey information. With multiple 
binding sites of CL to proteins, its synthesis as a molecule with a chiral asymmetry, its 
subsequent acyl exchange and re-modeling, then its requisite movement to non-
mitochondrial sites invite questions about understanding more about the remodeling process, 
why it occurs and how information from CL molecules is used to convey signals within and 
beyond the cell.
Diversity of Cardiolipins – Theoretically Possible vs Experimentally 
Detectable CL Species in Cells and Tissues Detectable by LC-MS
The structure of CLs with their four acyl chains (and 32 fatty acids) makes them not only 
unique but also one of the more structurally diverse lipid molecules with a potential diversity 
exceeding 106 molecular species across different types and classes of life. Considering 
possible CL metabolites, particularly oxidative metabolites with several oxygen-containing 
functionalities such as hydroperoxy-, hydroxy-, oxo-, epoxy- that may be formed in different 
positions of the polyunsaturated acyls and adding to this oxidatively-truncated CL 
derivatives – the total number of CLs and their metabolites may exceed 107 individual 
species. This huge diversity is not found experimentally as only some of the polyunsaturated 
fatty acids are present (Fig. 2), but tissue and cell specific CL diversity is broad and seems to 
be enzymatically and dynamically controlled. What is clear is that nutritional pressure as 
well as disease conditions associated with enhanced phospholipid oxidation may 
significantly increase the diversity of CLs. Assuming that CLs are used for signaling 
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purposes where every molecular species or a combination of several of them acts as a 
regulatory signal or a word in the signaling language, then the richness of this 
communication language is extraordinary. Notably, one can trace the evolutionary trends in 
the development of CL language. For example, 5 major fatty acids in prokaryotes (without 
oxidizable polyunsaturated species) can produce up to 625 species. The 14 major fatty acids, 
including polyunsaturated forms, in eukaryotes can produce 38,416 distinct CL species [93]. 
These numbers may increase an order of magnitude if CL oxidation products are included. 
Although these calculated levels of diversification are theoretically possible, most CLs 
reported in biological systems are enriched with a select number of fatty acids reducing the 
actual number of species observed [64].
There is currently no single comprehensive analytical method for identification of all 
possible CL species. Recent developments in soft ionization techniques and mass 
spectrometry (MS) have provided better insights into the identification and characterization 
of diverse CL species in biological systems [32]. Most protocols currently used for MS 
analysis of CL consist of two stages. A schematic outline of sample preparation extraction, 
lipid analysis, data and statistical analysis are presented in Supplemental Fig.1.
The first stage or MS1 distinguishes the species based on their molecular weight. Since 
many of the CL species are isomers this stage usually identifies groups of species that have 
the same molecular mass. For example 12 different molecular species of CL could account 
for the molecular weight of 1451 (m/z 1450.0) [80]. The second stage of mass spectrometric 
analysis or MS2 identifies the fragments generated from a particular CL molecule with a 
specific mass to charge ratio. Mass spectra obtained in MS2 provide the identities of acyl 
chains present in a particular CL molecule (Fig. 3) [94]. However the exact location of the 
acyl chains (regioisomers) cannot be identified.
The two most commonly utilized MS approaches for the analysis of CL include: shotgun 
lipidomics and chromatographic separation followed by tandem MS (LC-MS/MS). Shotgun 
lipidomics employs direct infusion of lipid extracts into the mass spectrometer. Using a 
shotgun lipidomics strategy, Han and colleagues identified 56 isomeric and ~100 individual 
molecular species (excluding regioisomers) of CL in mouse brain tissue [95]. Because CLs 
comprises a small percentage of total phospholipids it is often difficult to analyze them in 
sufficient detail without separation of lipid extracts by different chromatographic techniques. 
Different liquid chromatography (LC) techniques thus have been developed to separate 
phospholipids and enhance detection of CL [95-97]. Using a two-dimensional LC (2D-LC) 
MS, we have identified 178 individual molecular species of CL in rat brain [77]. Notably 
mammalian brain tissue has the most diversified CL assortment compared to other tissues 
[98, 99]. For example heart, liver and skeletal muscle display 39, 25 and 40, respectively, 
individual species of CL in mice; laboratory yeast cells have 17 and E. coli has 56 different 
CL species [95].
Recent developments in accurate mass and high sensitivity MS further expands the limits for 
identification and quantification of low abundance CL species in plasma and oxidized CL 
species in tissues [32, 41]. As an example, a newly developed Tribrid™ Ion-trap/Orbitrap™ 
technology (Fusion-Lumos, ThermoFisher Scientific) allows for unequivocal structural 
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characterization of very low abundance oxidation products of CL with identification of the 
positions of oxygen-containing group in the fatty acyls in MS3 spectra (Fig. 4). While these 
enhanced CL analytical methods improve the identification of diverse and low abundance 
CLs, the emerging challenges of lipidomics and redox lipidomics will be to discover the 
links between the low abundance CL species, including oxygenated CLs, and their 
functional roles in normal physiology and disease conditions.
Imaging mass spectrometry: CL distribution in neural tissues
As much as the power of contemporary LC-MS technologies allows for complete structural 
identification and in many cases quantitative analysis of different diversified CLs in 
organelles and cell bio-fluids the spatial distribution of CLs in tissues cannot easily be 
assessed by these protocols. Recent successes in MALDI-MS based imaging have resulted 
in the development of MS-imaging or “biochemical microscopy” [100], that has been 
applied to a number of different phospholipids [101]. Imaging mass spectrometry has the 
unique advantage of allowing the correlation of molecular mass to charge (m/z) information 
with the topographical (regional/spatial) orientation of a broad spectrum of analytes 
including peptides, proteins, lipids, small molecules/cellular metabolites, and drugs in a 
label-free manner [40, 101-103]. The low abundance and high diversification of CL in some 
tissues such as brain made it difficult to perform MS imaging of CLs on frozen tissue 
sections because of CL diversity and low abundant species. However, by using protocols that 
minimize interfering signals from the major membranes phospholipids – such as 
phosphatidylcholines and phosphatidylethanolamines – the task of imaging of CLs in brain 
has been resolved (Fig. 5). These techniques use a combination of chemical and enzymatic 
treatments of brain tissue sections combined with a modified matrix application device that 
allows for the visualization, mapping and fragmentation of CL species [101]. Employment 
of contemporary MALDI-MS equipment (e.g, RapiFlex™, Bruker-Daltonics) permits 
acquisition of excellent images of CLs in tissues with their utmost diversification, such as 
measured in brain.
Principles of Cardiolipin Binding to Proteins – Emphasis on Mitochondrial 
Proteins
Interactions of CL with proteins are pivotal for understanding many CL functions. 
Numerous proteins have been documented to interact with CL, and the presence of CL is 
essential for many of them structurally and functionally [104]. For instance, CLs bound to 
respiratory complexes III and IV are crucial for electron transport. The CL binding sites of 
cytochrome bc1 are located on the membrane-exposed surface of the respiratory chain 
complex III [105]. In addition to maintaining the structural integrity of complex III, CLs 
spontaneously diffuse to the interface of the cytochrome bc1 dimer to the higher potential 
heme b groups of the complex's catalytic Qi-site (the quinone reduction site), which suggests 
that CLs have a role in proton uptake [106]. In the same manner, CL molecules are tightly 
bound to cytochrome c oxidase, the terminal complex of the respiratory chain and are 
essential for its function [107]. Two CL binding sites of cytochrome c oxidase are involved 
in pathways linking CLs to the entrance of the D and H proton channels across the enzyme 
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complex, which highlights the role of CLs in the proton delivery machinery to complex IV 
[108].
Not only membrane proteins, but also several peripheral membrane proteins and even 
soluble proteins are known to interact with CL, stressing its role in diverse cellular 
pathways. For example, microtubule-associated protein 1A/1B-light chain 3 (LC3), which is 
involved in mitophagy, recognizes the externalized CL on the damaged mitochondria [109]. 
The double point mutation of two arginines in the N-terminus of LC3, an area rich in 
hydrophobic residues, diminished the degradation of defective mitochondria [109]. It has 
also been documented that nucleoside diphosphate kinase Nm23-H4/NDPK-D, binds to CL 
on the IMS side of IMM and transports CL to OMM through a proposed rotary machinery 
system [110]. Interestingly, the analysis of the CL-binding sites of these proteins revealed 
the presence of both, basic and hydrophobic residues, confirming the need for both, 
Coulomb and van der Waals forces in CL interactions with proteins.
To investigate the generality of this statement, a recent systematic analysis of known CL 
binding proteins with particular emphasis on those where structural information was 
available has been carried out [104]. An in-depth analysis of the amino acids, secondary 
structure elements and structural motifs in CL-binding sites in co-crystal structures allowed 
deriving of several common features. Most strikingly, CL-binding sites are highly flexible. 
This was suggested by a higher content of Gly, a lower content of Pro and predominance of 
coiled-coil secondary structure. Furthermore, as expected, overrepresentation of Arg and Lys 
in phosphate binding patches and of Leu, Ile, and Val in acyl chain binding patches 
confirmed the previously known involvement of electrostatic and hydrophobic interactions 
in binding. Further supporting the conclusion of the importance of positive charges is the 
fact that negatively charged residues (Asp and Glu) are either underrepresented or 
disallowed in head group binding sites. There was also an overrepresentation of Tyr in the 
head group binding region, which is a widely used residue in signaling due to its ability to 
be phosphorylated. Phosphorylation and the introduction of negative charge at a Tyr site 
would be expected to drastically alter CL binding properties. Specific super-secondary 
structural motifs also known as arches or iLoops [111] were also identified in binding 
patches (Fig. 6) and in particular loop MCL.GH.2.19.1, (Fig. 6A) which is characteristic for 
the mitochondrial ATP/ADP carrier. Paralleling previous studies in Protein-protein 
interactions [112, 113], it is tempting to speculate that this flexible loop containing a 
positively charged residue in the phosphate groups binding region, and a helix facilitating an 
anchor for acyl chain binding, may be considered a footprint for CL binding.
There are two areas that require further work, (1) the specificity of these features for CL, and 
(2) the classification of CL-binding modes according to protein/enzyme functions. Thus, 
future work needs to explore the generality of the findings for CL. In particular, other 
anionic phospholipids or other doubly negatively charged small molecules such as GDP or 
ADP may show overlap in the structural and dynamic features in their respective binding 
pockets. Furthermore, the CL binding mode and affinity to respiratory complexes, in which 
CL mainly is in bound state, may vary from proteins proposed to be involved in CL 
translocation —alternating bound/unbound states are essential for this functionality— either 
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between IMM and OMM (such as NDPK-D and mitochondrial creatine kinase) or across the 
membrane (like the adenine nucleotide translocator) [114, 115].
Interactions of Cytochrome c with Cardiolipins – Role in Catalysis of 
Cardiolipin Oxidation
Redistribution of CL between the IMM and OMM in depolarized mitochondria facilitates its 
interactions with unusual positively charged protein partners spatially separated in intact 
organelles. One of such partner is cyt c - a highly positively charged hemoprotein located in 
the IMS and shuttling electrons from respiratory complex III (cytochrome c reductase) to 
complex IV (cytochrome c oxidase) [116]. The disruption in the asymmetric distribution of 
CL, which occurs at the onset of apoptosis, leads to tight membrane binding of cyt c. The 
complex of cyt c/CL gains peroxidase activity realized in the presence of oxidizing 
equivalents such as H2O2 generated by disrupted electron transport activity or organic (lipid) 
hydroperoxides [59]. As CL is a highly selective substrate of the peroxidase reaction (see 
below), CL peroxidation is a characteristic feature of apoptosis required for the completion 
of this death program [117]. Not surprisingly, substantial efforts have been directed towards 
design and development of new inhibitors of cyt c /CL peroxidase activity as anti-apoptotic 
modalities [118, 119]. In spite of numerous studies [120-125] the universal structural 
characterization of CL-driven activation of cyt c into a peroxidase still has not been 
achieved.
Clearly, the peroxidase function of cyt c may require a subtle “loosening” or more 
substantial reorganization of its hexa-coordinated heme-iron environment [126]. The degree 
of the structural re-arrangements defines the potency of peroxidase activation. Several 
models based on detailed solid state NMR studies as well as crystallographic work suggest 
that small scale structural changes are sufficient for inducing the peroxidase competence of 
cyt c/CL complexes [127, 128]. These data complement the kinetic studies [129] in which a 
very early peroxidase activity was detectable before any substantial changes in the 
coordination of heme Fe with one of the axial ligands, (Met80), were detectable.
More profound structural changes realized via interactions with three CL-binding sites for 
cyt c were revealed by studies using solution NMR and molecular modeling (Fig. 7). 
Involvement of two binding sites located on both sides of a heme crevice introduces a 
membrane deformation and tight interactions. The ability to bind CLs simultaneously at the 
proximal and distal sides of the heme and the consequent induced strain due to this binding, 
opens up the heme crevice providing a path to the formation of the peroxidase. Thus 
simultaneous binding of the distal and proximal sites can be considered as “productive” 
binding mode leading to a robust peroxidase activation. Time-resolved FRET measurements 
of fluorescently-labeled cyt c revealed a conformational diversity of the CL-bound protein 
with distinct populations of the polypeptide structures that varied in their degree of protein 
unfolding [130]. Notably, a fraction of the complexes were strongly unfolded similarly to the 
fully denatured state of the hemoprotein induced by treatment with guanidine hydrochloride. 
Based on several studies of the peroxidase activation of cyt c by denaturing agents [131] it is 
likely that these “robustly” denatured forms of cyt c/CL complexes are mostly accountable 
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for the peroxidase activity. CL peroxidation requires the formation of a protein-immobilized 
radical, specifically tyrosyl radicals (Tyr•). The latter act as immediate reactive intermediates 
of the peroxidase cycle [132]. Among four tyrosines (Y48, Y67, Y74, and Y94), mutation of 
Tyr67 (Tyr67Phe), the closest to the heme-iron caused the most significant loss of the 
protein-immobilized radical EPR signal and loss of the peroxidase activity of the cyt c/CL 
complex [132]. This suggests the highly conserved Tyr67 and its radical are likely redox 
intermediates of the cyt c/CL peroxidase complex and formation of the radical is facilitated 
by the protein structural rearrangements that are necessary for CL peroxidation [132] [133] 
(Fig. 8). An interesting aspect of cyt c's involvement in CL peroxidation is its 
phosphorylation [134]. Notably, two tyrosines, Tyr97 in bovine heart and Tyr48 in bovine 
liver – but not Tyr67 - have been identified so far as phosphorylation sites in cyt c [132, 
135].
According to the results of computational modeling, one of the characteristic features of the 
peroxidase gain of function is that increasing the CL concentration enhances the affinity of 
cyt c for the membrane. Remarkably, cyt c recruits CL to form a cluster in the membrane, 
which demonstrates that multiple CL molecules (not individual molecules in isolation) 
stabilize the cyt c /CL complex. On the basis of coarse-grained molecular dynamics studies a 
model has been proposed [136] in which cyt c is partially and stably embedded in a locally 
curved and CL-rich membrane patch. In the context of patho-physiologically relevant events, 
the structural data clearly indicate that the “deepness” of cyt c rearrangements are dictated 
by the amounts of available CL in the membrane microenvironment. Translocation of CLs 
from the IMM to the OMM may be the major factor controlling peroxidase activation of the 
hemoprotein enhancing CL oxidation.
Mitophagy
Being central to the bioenergetics and regulation of metabolism, mitochondria also represent 
the major threat to the existence of cells, tissues and the entire organism. This teetering 
between the remarkable benefits offered by and dangers associated with mitochondrial 
functions has been known for more than five decades since the recognition of the substantial 
production of O2•− radicals and H2O2 by altered electron transport through the respiratory 
complexes [137-140]. Recently, it has become evident that several redox enzymes of the 
Krebs cycle (e.g. 2-oxoglutarate dehydrogenase (OGDH), branched-chain 2-oxoacid 
dehydrogenase (BCKDH), and pyruvate dehydrogenase (PDH) complexes are also capable 
of considerable superoxide/H2O2 production. The 2-oxoacid dehydrogenase complexes in 
mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex 
I [141] and represent an additional source of ROS with the rates of their generation 
exceeding that of electron transport [142]. This redox-associated imbalance (also called 
oxidative stress) is believed to potentially turn into a completely uncontrolled pro-oxidant 
reactions catalyzed by high concentrations of a variety of catalysts containing transition 
metals. Indeed, mitochondria are the site of heme synthesis and they are enriched with 
hemoproteins, in addition to abundant non-heme iron-sulfur clusters, and catalytic copper 
[143, 144]. Aside from the most potent inducers of redox stress, mitochondria's calamitous 
potential has become particularly obvious with the appreciation of the pro-apoptotic 
propensity of mitochondria-compartmentalized cyt c to facilitate the formation of 
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apoptosomes thus triggering the programmed apoptotic death pathway [145]. Moreover, 
activation of the intracellular pro-inflammatory machinery and extra-cellular immunogenic 
responses to mitochondrial DNA and formyl-peptides – the attributes of their association 
with the prokaryotic ancestors – add-up to the potential perilous consequences of 
mitochondrial dis-organization. Finally, because of the strict dependence of mitochondria on 
the trafficking of most of their proteins encoded by the nuclear genome, defective protein 
import may occur that results in the accumulation of mistargeted proteins as well as 
misfolded and aggregated proteins. These metabolic misfortunes cause stress responses the 
mitochondrial unfolded protein response (UPRmt) that aims to increase the capacity of 
protein quality control mechanisms inside mitochondria [146].
Not surprisingly, cells developed highly effective systems of mitochondrial quality control in 
which the prominent roles are played by the mitochondrial unfolded protein response and 
mitophagy - a specialized mitochondria-targeted process of autophagy, or piecemeal 
autophagy of mitochondrial subdomains. These specialized mechanisms appear to mitigate 
mitochondrial impairment [147] by removing dysfunctional mitochondria under normal 
physiological conditions and in response to pathological stresses.
Autophageal machinery delivers damaged mitochondria into double-membrane vesicles, 
autophagosomes, that eventually fuse with late endosomes or lysosomes where lysosomal 
enzymes degrade the autophagosome contents including the inner autophagosomal 
membrane. Selective autophageal cargo receptors (p62 and its paralog NBR1, NDP52 and 
its paralog T6BP, and optineurin) link their bound mitochondrial cargo to the 
autophagosomal membrane by interacting with lipidated (by phosphatidylethanolamine) 
ATG8 proteins, microtubule-associatedprotein-1 light chain 3 (LC3)/Gamma-aminobutyric 
acid receptor-associated protein (GABARAP) that are intimately associated with the 
autophagosome membrane cargo receptors [148]. A separate and important issue is the 
nature of signals on the surface of damaged mitochondria that are recognized by ATG8 
proteins. It is likely that both protein-based signals as well as lipid signals may be involved 
in the recognition process. Among the former the mitochondrial kinase PINK1 and 
subsequently recruited RBR E3 ubiquitin ligase, Parkin are believed to be involved in the 
detection of damaged mitochondria [149]. Among the latter, CLs have recently attracted 
significant attention as signaling molecules appearing on the surface of damaged 
mitochondria [26, 109]. The autophagy protein (LC3), which mediates both autophagosome 
formation and cargo recognition, contains CL-binding sites important for the engulfment of 
mitochondria by the autophagic system (Fig. 9).
In normally functioning mitochondria, CL is confined to the IMM, predominantly to its 
matrix-oriented leaflet in the proximity of the site of its synthesis (see above). Recognition 
by the cytosolic LC3 requires the presence of CL on the mitochondrial surface suggesting 
that trans-membrane re-distribution of CL has to take place in damaged mitochondria 
undergoing mitophagy. In mitochondria maintaining their membrane potential, the majority 
of the IMM CL is engaged in the interactions with different proteins, including ETC super-
complexes and only negligible amounts of CL are present in protein-free form [89]. This is 
well illustrated by recent 31P-magic angle NMR data demonstrating essentially lack of 
discernable CL-derived signals from normal mitochondria [150]. This organization, 
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including the tight binding of CL, is dramatically changed in depolarized mitochondria 
treated by protonophoric uncouplers and other mitochondria damaging agents. Indeed, direct 
LC-MS measurements established significant enrichment of the OMM with CL [151] after 
exposure to the uncouplers, rotenone, staurosporine, 6-hydroxydopamine. Because 
molecular speciation of the IMM and OMM CL is very similar, it is most likely that 
redistribution - rather than activation of biosynthetic pathways - is mostly accountable for 
the externalized on the mitochondrial surface CL [80].
The information on the mechanisms of CL-translocation from the IMM to the OMM is 
scarce. Assuming that most of the CLs are present on the matrix side of the IMM, three steps 
are required for CL to reach the mitochondrial surface; i) through the IMM, ii) through the 
intermembrane space, and iii) through the OMM. In spite of the significant progress in 
characterization of the machinery for protein trafficking into mitochondria, the mechanisms 
of CL translocations remain largely unknown. Recent studies indicate that a hexameric 
intermembrane space protein, NDPK-D (or NM23-H4), binds CL and facilitates its 
redistribution to the OMM thus identifying one of the candidate proteins involved in the CL 
transfer through the intermembrane space [151]. The putative binding site of the protein is in 
the proximity of R90 as established by the loss of activity in R90D mutants of NDPKD. 
Interestingly, the affinity of NDPKD for CL is not high suggesting that there may be an 
important threshold effect preventing excessive sensitivity of the transfer mechanisms to 
stochastic fluctuations of CL concentrations. This specific feature is also important for the 
prevention of withdrawal of CL from its associations with many mitochondrial proteins. The 
regulation of the transfer process may include several control mechanisms. Mitophagy-
inducing CL-transfer activity of NDPK-D is closely associated with the dynamin-like 
GTPase OPA1, implicating fission-fusion dynamics in mitophagy regulation. In agreement 
with this regulatory mechanism, CL binding suppresses kinase activity of NDPKD. While 
the overall dependence of mitophagy and CL externalization on the total content of CL and 
its integrity have been established, the translocation mechanisms of CLs within IMM and 
OMM are yet to be deciphered although several proteins have been proposed as suspects. 
For example, uncoupling proteins and anionic transporters in the IMM as well as 
phospholipid scramblase-3 in the OMM may participate in the respective translocation 
pathways [26]. The necessity of focused research in this area is emphasized by the 
discovered associations between disturbances in CL metabolism and mitophagy in disease 
(eg, Barth syndrome, Parkinson disease [33, 46, 152, 153].
Selective Cardiolipin Oxidation: Role in Apoptosis
There is a belief that excessive production of superoxide radicals in mitochondria by ETC 
and Krebs cycle dehydrogenases may cause poorly controlled random reactions of chemical 
oxidation of different biomolecules, including (phospho) lipids [143, 154]. This concept has 
brought to life the idea of antioxidants - acting predominantly via mechanisms of free 
radical scavenging – as protectors against oxidative stress and its exuberant manifestations 
as oxidative injury. While the concept may still retain its value as an interesting chemical 
excursion into the land of metabolic biochemistry under extreme conditions, experimental 
tests and clinical trials have not provided any significant support to the dominant stochastic 
chemistry of oxidation reactions in cells, tissues and the body [155]. In contrast, alternative 
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ideas of enzymatically regulated oxidative reactions, including reactions of phospholipid 
peroxidation, have been put forward as the leading cause of oxidative signaling whereby dis-
regulation of these reactions may lead to the accumulation of excessive amounts of lipid 
oxidation products, albeit in specific rather than random molecular targets [156].
One of the most informative approaches to experimental testing of these ideas is via the use 
of redox lipidomics based on quantitative and structural characterization of phospholipid 
oxidation products. Because the rate of lipid oxidation strongly depends on the number of 
double bonds in the molecule, phospholipids are expected to be oxidized dependently on the 
levels of their poly-unsaturation rather than on the nature of their polar head-group [157]. In 
contrast, enzymatically catalyzed oxidation reactions may affect specific classes of 
phospholipids. With this in mind, it is interesting to perform analysis of the specificity of 
phospholipid peroxidation in several experimental models of tissue injury leading to a 
specific type of programmed cell death, apoptosis. Brain trauma, neuronal damage after 
cardiac arrest, substantia nigra after exposure of animals to rotenone, hyperoxia and 
nanoparticle exposure of the lung, gamma-radiation induced damage to small intestine have 
been long recognized to initiate tissue damage and mitochondria-mediated intrinsic 
apoptotic cell death accompanied by characteristic and significant oxidative damage. 
Intriguingly, a very high level of phospholipid specificity has been discovered as one of the 
most characteristic features of oxidation reactions triggered by these very different stimuli in 
different tissues with the common denominator – massive apoptosis. Mitochondrial CLs 
were found universally and most abundantly oxidized during injury associated with these 
insults [25, 41, 77, 80, 158]. Strikingly, CL oxidation turned to be non-random as well but 
had a pronounced specificity unrelated to the pattern of CL polyunsaturation. Accumulation 
of hydroxyl- and hydroperoxy- derivatives of CL was observed in tissues of the affected 
animals whereby C18:2 acyls – rather than more polyunsaturated C20:4, C22:5 or C22:6 
acyls – were predominantly involved in the oxidation process. This suggests that a specific 
enzymatic mechanism, such as cyt c/CL peroxidase, might be predominantly responsible for 
the production of pro-apoptotic death signals [80].
A recently developed optolipidomics approach based on a combination of high affinity light-
sensitive ligands for CL with LC-MS based lipidomics demonstrated selective accumulation 
of hydroxy- and hydroperoxy-C18:2-containing CL species in mouse embryonic fibroblasts 
and HeLa cells triggered to apoptosis [159]. In this case, selectivity of intrinsic apoptotic 
death has been achieved by photo-oxidation of mitochondria-accumulated and CL-selective 
dye, nonyl-acridine orange and confirmed by a bioinformatics n-gram analysis. Similar 
oxygenated CL-derived death signals were detected in cells during apoptosis triggered by 
different stimuli such as actinomycin D [160], staurosporine [39], mechanical stretch of 
neurons [77], rotenone [97], hyperoxia [161] and ionizing radiation [162]. Notably CL 
oxidation is highly specific for apoptotic but not other types of programmed cell death. In 
fact CL oxidation is selectively excluded from ferroptotic cell death, where phosphatidyl-
ethanolamine (PE) plays a signaling role [163].
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Intra- and Extra-Cellular Cardiolipin Regulation of Immune Responses
In addition to acting as a regulatory platform for intra-mitochondrial and intra-cellular 
metabolism, CLs can also participate in defining and fine-tuning immune responses. As 
descendants of protobacteria that entered into an endosymbiotic relationship with ancestral 
anaerobes, mitochondria bear unique microbial molecular motifs - pathogen associated 
molecular patterns (PAMPs) recognized by the innate immune system [164]. Hidden from 
the mitochondrial surface CLs can, upon externalization to the surface and release into 
extracellular environments, serve as a source of PAMP like danger-associated molecular 
patterns (DAMPs) [164, 165]. Thus, the process of CL translocation may be not the end 
rather the beginning of the CL-driven journey in which the major roles are played by 
different components of the immune system.
Intracellular Signaling via Inflammasome Activation
Damaged (depolarized) mitochondria with externalized CL represent one of the common 
intracellular activating stimuli for the responses of innate immune cells realized via the 
formation of inflammasomes. One of them, NLRP3 inflammasome, activates caspase-1 
[166] ultimately leading to the proteolytic activation of the pro-inflammatory cytokines, 
interleukin-1β (IL-1β) and interleukin-18 (IL-18) [167]. Several features indicate that 
mitochondria with externalized CLs are tightly involved in the activation of NLRP3 
inflammasomes: i) relocation from endoplasmic reticulum to mitochondria [168] ii) negative 
regulation by mitophagy/autophagy [169, 170] iii) dependence of inflammasome activation 
on CL contents (e.g. via knockdown of cardiolipin synthase); iv) CL binding to the leucine 
rich repeat (LRR) region of Nlrp3; v) direct activation of the inflammasome by CLs [171]. 
While the nature of the inflammasome activation signal produced by damaged mitochondria 
still is not fully identified, it is likely that CL externalized to the surface can serve as a 
mitochondrial docking site for the inflammasome assembly and subsequent activation or 
alternatively as the direct activating ligand for NLRP3 (Fig. 10), [171, 172].
Extracellular signaling: phagocytosis and immune-suppression
Dying or injured cells can release mitochondria and mitochondrial fragments with 
externalized CLs [173-175] which – similarly to phosphatidylserine (PS) – can be 
recognized by professional phagocytes as an “eatme” signal for uptake and degradation. 
Indeed, it has been demonstrated that mitochondria or liposomes with CLs exposed on their 
surface attract phagocytes and stimulate engulfment mediated through the cell surface 
scavenger receptor CD36 [22]. Of note, the effectiveness of the uptake is not dependent on 
CL oxidation – similar to autophagy of mitochondrial with externalized CL [24]. 
Independently of the uptake process, membranes with integrated CL can be effectively 
bound by the phagocyte Toll-like receptor 4 (TLR4)/Md2. The significance of the latter 
interaction becomes particularly obvious in the context of the inflammatory response elicited 
by macrophages challenged and activated by the bacterial agonist lipopolysaccharide (LPS). 
The antigenicity and inflammatory potency of LPS is defined by hexa-acylated Lipid A 
[176, 177]. By acting as a structural homologue of antigenically inactive immature Lipid A, 
CL potently suppresses TLR4/Md2-driven cytokine production and release thus causing 
immune-paralysis [22]. This dichotomous role for extracellular CL - as an “eat-me” signal 
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and inhibitor of the innate immune response – should be considered in the context of host-
pathogen relationships and recognition of (PAMPs).
Adaptive immune response and anti-CL antibodies
The continuous presence of CL externalized on damaged mitochondria – due to failure of its 
effective removal by the innate immune system or constant production as a result of cell 
death - can activate antigen-presenting cells (APCs) such as dendritic cells (DC) and 
macrophages and, through interactions with T cells and B cells, stimulate the adaptive 
immune response resulting in the production of anti-CL antibodies [178]. These effects of 
CLs may be stimulated by beta-2-glycoprotein 1 (β2GPI), a glycoprotein present in high 
concentrations in plasma and capable of effective binding to anionic phospholipids, 
including CLs [179, 180]. Excessive formation and accumulation of antiphospholipid 
antibodies, particularly antibodies against CLs, may lead to the development of a systemic 
autoimmune disease - the anti-phospholipid syndrome (APS). Recent studies indicate that 
viral infection provoked damage of mitochondria, CL externalization and impaired 
mitophagy may be essential in the development of Lupus erythematosus and other systemic 
autoimmune diseases [178].
Concluding remarks and future directions
Mitochondria have retained a number of their ancestral bacterial attributes including 
retention of the bioenergetic molecular machinery for making ATP, a bacterial type genome 
(albeit diminutive) and the conservation of the ancient prokaryotic phospholipid CL. In 
multicellular eukaryotic organisms, mitochondria have evolved to do so much more than 
their prokaryotic ancestors. The role of mitochondria in regulating cellular energy balance, 
oxidant production, mitochondrial biogenesis, mitophagy, cell death pathway(s) and innate 
immunity, now define their central role in sensing metabolic and invasive perturbations that 
are essential for controlling cellular stability and homeostasis. Cardiolipin has a role in all of 
these functions. Over the 75 years since its discovery, remarkable progress in the 
understanding of the roles that CLs and their metabolites play in mitochondrial functions has 
been attained. One of the latest achievements is the discovery of multiple signaling functions 
of CLs not just within mitochondria but also in cells and the entire body.
Perhaps the single most important tool used to measure CLs and their oxidized products is 
MS which has proven invaluable in most modern studies of lipids including CLs. Increasing 
sensitivity and mass accuracy, sample handling and sophisticated lipidomic analysis have 
continued to improve, providing better structural characterization and more reliable 
quantitative measurements of CLs and their products. The identification of the myriad of 
CLs and their oxidized products may be compared with the discovery of a CL-based 
language for effective signaling. However, the structure of this language, its grammar, words 
and even its “alphabet” are still unknown. Significantly more work in which not only 
improved technologies, including MS-based technologies, but also more advanced lipidomic 
and bioinformatics analysis combined with focused molecular and cell biology experiments 
will be necessary.
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Still unexplained, several mysteries of CL should be mentioned. The synthesis of CLs is 
lacking specificity in regards to a detailed explanation of the formation of tissue specific 
homo-acylated and hetero-acylated CL as well as their functions. Cells go to an energetically 
costly effort to produce homo-acylated CLs. In mammalian cardiac cells ~80% of the CL 
has 4 identical tetra-linoleoyl chains, how and why this is done is unclear. The responsible 
biosynthetic pathways involved still wait for their accurate identification; so do specific 
functions of tetra-linoleoyl-CL in the heart and skeletal muscles. Hetero-acylated CL present 
in all mammalian tissues and notably in brain are the likely precursors of many CL signals, 
particularly lipid mediators whose identification and physiological roles are still obscure.
While the differences in diversity, molecular speciation and susceptibility to oxidation 
between bacterial and mitochondrial CLs have been overall known, surprisingly, one of the 
central issues - the cross-communications of bacterial and mitochondrial CLs during 
infection still remain enigmatic. One may also wonder whether the role of mitochondrial 
symbionts in host cells is always beneficial or the evil “call of the wild” can be awakened in 
mitochondria in the face of the invasion by extra- and intracellular bacterial pathogens. 
Many CL-dependent features of host/pathogen relationships are yet to be explored. As one 
of the examples, mitochondria and bacteria share the common evolutionary conserved 
mechanisms for CL externalization that are used for signaling purposes – elimination of 
dysfunctional mitochondria via mitophagy and virulence/survival for the host cells and 
bacterial pathogens, respectively. Molecular speciation of externalized CLs defines the 
specific meaning of the CL-encoded signals. Given the recently established redistribution of 
CLs from the inner to the outer membrane of intracellular bacterial pathogens upon the 
encounter with a host cell, it is tempting to speculate that these externalized pathogen CLs 
act as a signal by mimicking mitochondrial CLs. This facilitates effective uptake and 
delivery of bacteria into the endo-phagosomal compartment of host cells thus facilitating the 
growth and subsequent proliferation of bacteria. Based on this new concept, new anti-
bacterial peptides with a high affinity towards externalized bacterial CLs can be designed. 
Moreover, the protein machinery involved in the CL externalization process may represent 
new targets for drug discovery. By mimicking mitochondrial CLs – bacterial non-oxidizable 
CL species may interfere with the critical signaling by oxygenated species thus hijacking 
essential mammalian metabolic networks. Understanding this may lead to targeted 
employment of PUFA-containing CLs as antibacterial agents.
Mitochondria are known to act as epigenomic regulators, however the nature of the signals 
causing chromatin-modifying agents remains largely unknown. Similar to ancient ‘quorum 
sensing’ mechanisms of bacterial communities, mitochondria are believed to act as networks 
generating integrated signals essential for cell adaptation and plasticity [181]. It is possible 
that CLs represent important signals integrating intracellular and extracellular signaling 
systems. Mitochondria with externalized CLs released from dying cells (via necrosis, 
necroptosis or ferroptosis) may confuse professional phagocytes resulting in “false” uptake 
and mishandled innate immune responses. Mitochondria-targeted stabilizers may attenuate 
these undesirable effects.
Polyunsaturated CLs of eukaryotes evolved with aerobic life and are essential for 
coordination of multicellular organization. Tracing of the evolutionary development of the 
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“cardiolipin-ome” will contribute to understanding the fundamental principles of 
mitochondrial CL signaling.
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• Cardiolipin (CL) is a unique ancient lipid common to bacteria and 
mitochondria
• Cardiolipin is essential for mitochondrial bioenergetic functions
• While located in the inner membrane, CL can externalize to signal mitophagy
• Enzymatic oxidation of mitochondrial cardiolipins is required for apoptosis
• Oxidized CL are precursors of lipid mediators
• Diversification of mitochondrial CLs is tissue specific
• Homo-acylated CLs are characteristic of the heart
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Fig. 1. Highly diversified molecular speciation of cardiolipin are typical of fish tissues compared 
to the high uniformity of CLs in bovine heart
A. LC-MS spectra of CLs from brain, skeletal muscle and heart from a Northern Red 
Snapper (Lutjanus campechanus) and bovine heart CL. The m/z shown are for the most 
abundant species in each cluster of CL. The CL species with m/z of 1447.9653 (72:8) is the 
major species in bovine heart but not in fish heart. B. Spider graph plots of the number (left 
panel) and amounts (right panel) CL molecular species in fish and bovine hearts. Species are 
presented as a ratio of carbon to double bonds number (C:DB). For clarity, the scales for the 
number of CL species in bovine heart (pale pink, left panel) and for the amount of CL 
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species in fish heart (pale blue, right panel) were magnified in 4 and 5 times respectively. C. 
Cardiolipin structure. A pro-chiral carbon (1) is located on the central glycerol. The 4 acyl 
chains (R1, R2, R3 and R4) are linked to 2 glycerols each with a chiral carbon with the same 
(R) chirality on the left and right side of the molecule (2,3), highlighted by the shading. The 
phosphates are charged at physiological pH.
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Fig. 2. Expansion of the diversity of CLs
The initially synthesized 4 CL acyl chains can be saturated, mono- unsaturated or poly-
unsaturated. Remodeling is initiated by deacylation of one or more acyl chains and with 
enzymatic precision a wide variety of fatty acids can re-acylate the lyso-CLs forming organ 
and tissue specific variations of CL content.
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Fig. 3. Detailed structural information can be obtained by contemporary high resolution MS 
equipment: The Orbitrap™ high energy collision dissociation (HCD) MS2-spectra of 
cardiolipins with the [M-H]- ion at m/z 1371.9359
Two isomers CL(18:1/18:1/18:1/18:2) and CL(16:0/18:1/18:0/20:4) were identified. 
CL(18:1/18:1/18:1/18:2) (in blue): The characteristic structural fragments includes: 
[PG(18:1/18:1)+Phosphate-H]− and [PG(18:1/18:2)+Phosphate-H]− ions of m/z 835 and m/z 
833, respectively; neutral loss (NL) of phosphate group from above moieties generating 
[PG-H]− ions with m/z 755 and m/z 753, respectively. [PA(18:1/18:1)-H]− and 
[PA(18:1/18:2)-H]− ions of m/z 699 and m/z 697, respectively; NL of C18:1 from above PA 
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moieties generating m/z 417 and m/z 415 (box), respectively. The individual fatty acid 
carboxylate anion was also observed with m/z 281 and m/z 279, corresponding to C18:1 and 
C18:2, respectively. CL(16:0/18:1/18:0/20:4) (in red): The characteristics structural 
fragments includes: [PG(16:0/18:1)+Phosphate-H]− and [PG(18:0/20:4)+Phosphate-H]− 
ions of m/z 809 and m/z 859, respectively; [PA(16:0/18:1)-H]− and [PA(18:0/20:4)-H]− ions 
of m/z 673 and m/z 723, respectively; neutral loss (NL) of fatty acids from above PA 
moieties generating m/z 417, 391, 439 and 419 (box). The individual fatty acid carboxylate 
anion was also observed with m/z 255, 281, 283 and 303, corresponding to C16:0, C18:1, 
C18:0 and C20:4, respectively. m/z 153 was ion of glycerol-3-phosphoate with NL of H2O, 
the characteristic ion of phospholipids. Shared fragments were marked in black in MS/MS 
spectra. Abbreviation: NL, neutral loss; PA, phosphatidic acid; PG, phosphatidylglycerol
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Fig. 4. MS2/MS3 fragmentation analysis leads to detailed structural characterization of oxidized 
CLs
An example showing the increased resolution of the structural characterization of CL-
(C18:2)4 hydroperoxy molecular species formed in an AAPH (2,2'-azobis-2-methyl-
propanimidamide, dihydrochloride) driven reaction using a Tribrid™ MS Fusion Lumos 
(Thermo Fisher Scientific, San Jose, CA). A. Full, MS2 and MS3 spectra of (hydroperoxy-
C18:2)1(C18:2)3. Daughter molecular ions formed during MS2 analysis corresponding to the 
oxygenated C18:2 are shown in red. Characteristic fragments of 9-hydroperoxy-C18:2 and 
13-hydroperoxy-C18:2 formed during MS3 analysis are shown in blue. B. The structures of 
Maguire et al. Page 36













the detected nascent CL (C18:2)4 and two of its oxidized products, (9-hydroperoxy-
C18:2)1(C18:2)3-CL and (13-hydroperoxy-C18:2)1(C18:2)3-CL as identified and 
characterized using MS2/MS3.
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Fig. 5. Biochemical microscopy by MALDI-MS imaging reveals the differential distribution of 
CL species in various anatomical areas of the brain
Serial rat brain coronal sections were prepared. The left panel shows an optical image from a 
hematoxylin and eosin stained section using a Nikon-90i™ microscope. MALDI-MS 
imaging detects 23 species of CL at a lateral resolution (pixel size) of 50 microns, two of 
these species are shown in the middle and right panels. Predominantly saturated species of 
CL such as CL(70:4) (middle panel) are strongest in the hippocampal region (H), especially 
the dentate gyrus (DG), and moderately less intense in the cortex (C) and ventricles ( V). 
Highly unsaturated species of CL such as CL(76:12) (right panel) are strongest in the cortex 
and ventricles (C, V) and less intense in the hippocampus (H). The images were acquired on 
a Bruker Daltonics-RapiFlex™ MALDI, using the protocol from [101]. Ions detected as [M-
H]1- and intensities are relative with respect to the given ion. The white bar = 1 mm.
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Fig. 6. Computer modeling illustrates the major modes of CL interactions with proteins
Structural details of the interaction between CL and: (A) the ATP/ADP carrier (PDB 1okc); 
(B) the cytochrome C oxidase (PDB 3w7g) and cytochrome C1 heme protein (PDB 1P84). 
The CL molecule is shown in sticks, oxygen atoms in red, phosphorus atoms in orange and 
carbon atoms in pale gray. When super-secondary structural motifs (loops) were identified 
near the CL molecule, these are highlighted in cyan (helix) and light-pink (coiled coil) 
colors (A and B) the closest protein region is shown in light blue (C). Over the cartoon 
representation of secondary structures, a mesh network displays physico-chemical properties 
of amino-acids neighboring the CL molecule: in orange, hydrophobic; in blue: positively 
charged; in red, negatively charged. The key CL-binding motif [KR]-(X)-G is highlighted 
using sticks representations and lime-green color for Gly and blue-purple color for Arg/Lys.
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Fig. 7. Molecular dynamic simulations illustrate different modes of cyt c interactions with CL-
containing lipid bilayers
Two separate binding orientations are shown. A) Productive binding involves tighter 
interactions and deeper penetration into the membrane facilitated by CL sequestration 
leading to peroxidase activation. B) Unproductive binding engages smaller amounts of 
sequestered CL and does not lead to peroxidase activation.
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Fig. 8. Partial x-ray structure of cyt c illustrates the proximity of a candidate Tyr residue 
involved in peroxidase activation by CL
The upper panel shows the positions of the cyt c tyrosines (Y48, Y67, Y74, and Y94). Y67 
is located in the closest proximity to the heme-iron (lower panel). Y67 acts as a donor of an 
electron for a porphyrin cation-radical generated as a reactive peroxidase intermediate. In the 
oxygenase half-reaction of the cyt c /CL peroxidase complex, Y67 radical acts as an electron 
acceptor from oxidizable CL.
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Fig. 9. Externalization of CLs to the mitochondrial surface occurs during mitophagy whereas 
oxidation of CLs is necessary for the execution of apoptosis
In mitophagy CL is translocated by NDPK-D which binds to both the IMM and OMM, 
facilitating CL movement to the OM where it can bind and activate LC3-II which initiates 
autophagosome formation leading to mitophagy. In the figure the CL is colored blue, other 
lipids are brown and oxidized CL is colored red. In apoptosis CL forms a complex with cyt c 
converting it to a peroxidase, H2O2 is used as the oxidant of CL and the net result is the 
release of cyt c through the OMM and into the cytoplasm, as well as externalization of CL to 
the OMM resulting in apoptotic death.
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Fig. 10. Intra- and Extracellular CLs are involved in the regulation of the immune responses
The left panel shows that mitochondrial externalized CLs are involved in the activation of 
NLRP3 inflammasomes, which in turn activates caspase-1; The middle panel shows that 
LPS (which contains lipid A) cross-links two TLR4-MD2 complexes to activate an 
inflammatory response. However, CL only binds to MD2, but cannot cross-links TLR4's; In 
the right panel, mitochondria with externalized CL have characteristics of bacteria. CD1d 
protein is able to bind and present mammalian or bacterial CL to CL-responsive γδ T cells 
that exist in the spleen and liver of healthy mice. In response to CL these cells proliferate in 
a dose-dependent manner, and secrete the cytokines IFN-γ and RANTES.
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